All In Biotech

Drug Trial Radar · NCT01335412

Safety Surveillance After Immunization With IXIARO

Active Surveillance for Adverse Events After Immunization With IXIARO(R) Among U.S. Military Service Personnel

Last checked: Nov 20, 2026Latest source record: Mar 10, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

20,000

Actual

Start

Mar 2011

Primary completion

Jun 2013

Study completion Jun 2013

Sponsor

Lead sponsor
Valneva Austria GmbHIndustry
Sponsor type
Industry
First posted
Apr 14, 2011

More drug trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an active electronic surveillance using data from the Defense Medical Surveillance System (DMSS) to detect and characterize serious, rare adverse events occurring within 42 days after vaccination with the Japanese Encephalitis Vaccine IXIARO within the US Military, to detect adverse events that occur more frequently after IXIARO and to electronically follow up pregnancies during or shortly before which IXIARO was administered. There will be no intervention and no individuals contacted.

Conditions

  • Japanese Encephalitis

Interventions

  • Japanese Encephalitis Virus vaccine, inactivated, adsorbedBiological

    2 x 6mcg / 0.5mL intramuscular injection, Day 0 and 28 (Primary series) or 1x 6mcg / 0.5mL intramuscular injection (Booster)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of pre-defined, serious adverse eventsTime frame: 42 days after each dose of IXIARO

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Military Vaccine Agency

    Alexandria, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.